Nuformix PLC Stmnt re Share Price Movement (6309K)
April 11 2018 - 11:41AM
UK Regulatory
TIDMNFX
RNS Number : 6309K
Nuformix PLC
11 April 2018
Nuformix plc
("Nuformix" or "the Company")
Statement re: Share Price Movement
Nuformix (LSE: NFX.L), the pharmaceutical development company
using cocrystal technology to unlock the therapeutic potential of
approved small molecule drugs, notes the recent share price
movement and confirms that the Company is conducting a number of
commercial discussions relating to its product pipeline, however,
these meetings are still at an early stage and may or may not
result in material agreements for the Company. Further update
announcements will be made as and when appropriate.
Nuformix plc shares are traded on the London Stock Exchange's
Official List under the ticker: NFX.L. Follow Nuformix on Vox
Markets: follow at: www.voxmarkets.co.uk/company/NFX
and the Company's web site at: www.nuformix.com
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014.
ENDS
Enquiries:
Nuformix plc
Dan Gooding, Chief +44 (0)1223 423
Executive Officer 667
Gable Communications
Ltd
John Bick / Justine +44 (0)20 7193
James 7463
About Nuformix plc www.nuformix.com
Nuformix is a pharmaceutical development company using cocrystal
technology to unlock the therapeutic potential of approved small
molecule drugs. Nuformix' risk-mitigated development strategy has
resulted in a pipeline of discoveries through which it has
developed and patented novel cocrystal forms of approved small
molecules.
Nuformix has created an IP portfolio containing a range of
granted patents covering cocrystal forms of five small molecule
drugs. Nuformix is targeting high-value unmet needs with its lead
programmes in oncology supportive care: NXP001 and fibrosis:
NXP002.
Nuformix was established in Cambridge in 2008 and has invested
into pharmaceutical cocrystal R&D, establishing world-class
capability and know-how in cocrystal discovery and development,
yielding multiple product opportunities. Nuformix plc shares are
traded on the London Stock Exchange's Official List under the
ticker: NFX.L.
This information is provided by RNS
The company news service from the London Stock Exchange
END
SPMUAOVRWWASAAR
(END) Dow Jones Newswires
April 11, 2018 11:41 ET (15:41 GMT)
Nuformix (LSE:NFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nuformix (LSE:NFX)
Historical Stock Chart
From Apr 2023 to Apr 2024